Skip to main content
Clinical Trials/CTRI/2023/11/059969
CTRI/2023/11/059969RecruitingPhase 3

Effect of HYDRASTININUM MURIATICUM and HOMOEOPATHIC CONSTITUTIONAL MEDICINE on improving the quality of life of patients with LEIOMYOMA - a quasi experimental study - NI

Dr Dilna KP0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients with signs and symptoms of Uterine fibroid
  • 2.Patients of uterine fibroid with USG findings.
  • 3.Women of age 20-50 years
  • 4.Fibroid size upto 7cm

Exclusion Criteria

  • 1.Pregnant and lactating women
  • 2.Hb < 7 gldl
  • 3.Complications of fibroid like torsion (immediate surgical management)
  • 4.Patients with adenomyosis, ovarian tumors and uterine cysts.
  • 5.Extra- uterine fibroid, polyp, cervical fibroid and any fibroid causing hydronephrosis
  • 6.Malignancy of genitourinary tract or history of any malignancy

Investigators

Sponsor
Dr Dilna KP

Similar Trials